New therapeutic strategy for atopic dermatitis by targeting CHI3L1/ITGA5 axis
暂无分享,去创建一个
D. Son | Sukgil Song | Chong-Kil Lee | Ji Eun Yu | J. Hong | J. Yun | Min Ji Kim | S. Han | Seongsill Jeon | Hyeon Joo Ham | Y. Lee
[1] T. Bieber,et al. Serum receptor activator of nuclear factor kappa‐Β ligand/osteoprotegerin ratio correlates with severity and suggests fracture's risk in older women with atopic dermatitis , 2021, Allergy.
[2] J. Hong,et al. Inhibition of Chitinase-3-like-1 by K284-6111 Reduces Atopic Skin Inflammation via Repressing Lactoferrin , 2021, Immune network.
[3] Xiaoren Zhang,et al. Chitinase-3 like-protein-1 function and its role in diseases , 2020, Signal Transduction and Targeted Therapy.
[4] M. N. Kim,et al. Chitinase 3‐like 1 drives allergic skin inflammation via Th2 immunity and M2 macrophage activation , 2019, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[5] P. Korošec,et al. SPINK5 is associated with early‐onset and CHI3L1 with late‐onset atopic dermatitis , 2017, International journal of immunogenetics.
[6] J. Szepietowski,et al. Chitinase-3-Like Protein 1 (YKL-40) Reflects the Severity of Symptoms in Atopic Dermatitis , 2017, Journal of immunology research.
[7] Li Lin,et al. Chitinase 3-like 1 induces survival and proliferation of intestinal epithelial cells during chronic inflammation and colitis-associated cancer by regulating S100A9 , 2015, Oncotarget.
[8] Donald Gullberg,et al. Integrins , 2009, Cell and Tissue Research.
[9] R. Shao,et al. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis , 2009, Oncogene.
[10] B. Imhof,et al. Adhesion molecules in atopic dermatitis: upregulation of alpha6 integrin expression in spontaneous lesional skin as well as in atopen, antigen and irritative induced patch test reactions. , 1997, International archives of allergy and immunology.